References
- Freeman R, Abuzinadah AR, Gibbons C, et al. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(11):1294–7.
- Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72.
- Claassen DO, Adler CH, Hewitt LA, et al. Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers. BMC Neurol. 2018;18(1):125.
- Merola A, Romagnolo A, Rosso M, et al. Autonomic dysfunction in Parkinson’s disease: a prospective cohort study. Mov Disord. 2018;33(3):391–397.
- Northera® (droxidopa). Full Prescribing Information. Deerfield IL: Lundbeck NA Ltd; 2017.
- Kaufmann H, Malamut R, Norcliffe-Kaufmann L, et al. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res. 2012;22(2):79–90.
- US Food and Drug Administration, US Department of Health and Human Services. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. cited 2020 Jul 21. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims
- US Food and Drug Administration. CDER patient-focused drug development. cited 2020 May 4. https://www.fda.gov/drugs/development-approval-process-drugs/cder-patient-focused-drug-development
- European Medicines Agency. Terms of reference for the EMA/FDA cluster on patient engagement. cited 2020 May 4. https://www.ema.europa.eu/en/documents/other/terms-reference-european-medicines-agency/food-drug-administration-cluster-patient-engagement_en.pdf
- François C, Shibao CA, Biaggioni I, et al. Six-month use of droxidopa for neurogenic orthostatic hypotension. Mov Disord Clin Pract. 2019;6(3):235–242.
- Kempen GI, Yardley L, van Haastregt JC, et al. The Short FES-I: a shortened version of the falls efficacy scale-international to assess fear of falling. Age Ageing. 2008;37(1):45–50.
- Leon AC, Olfson M, Portera L, et al. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med. 1997;27(2):93–105.
- Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
- Göktaş A, İşçi Ö. A comparison of the most commonly used measures of association for doubly ordered square contingency tables via simulation. Metodološki zvezki. 2011;8(1):17–37.
- Tang W, Hu J, Zhang H, et al. Kappa coefficient: a popular measure of rater agreement. Shanghai Arch Psychiatry. 2015;27(1):62–67.
- Altman DG. Some common problems in medical research. In: Altman DG, editor. Practical statistics for medical research. London Uk: Chapman & Hall/CRC; 1991. p. 396–439.
- Rockwood K, Fay S, Hamilton L, et al. Good days and bad days in dementia: a qualitative chart review of variable symptom expression. Int Psychogeriatr. 2014;26(8):1239–1246.
- Williams V, Ryan S. “I just know”: exploring self-knowledge in chronic obstructive pulmonary disease. Palgrave Commun. 2017;3(1):17089.
- Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
- Reilly MC, Gerlier L, Brabant Y, et al. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn’s disease. Clin Ther. 2008;30(2):393–404.
- Reilly MC, Bracco A, Ricci JF, et al. The validity and accuracy of the Work Productivity and Activity Impairment questionnaire–Irritable Bowel Syndrome version (WPAI:IBS). Aliment Pharmacol Ther. 2004;20(4):459–467.
- Chen H, Blanc PD, Hayden ML, et al. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health. 2008;11(2):231–239.
- Pihet S, Moses Passini C, Eicher M. Good and bad days: fluctuations in the burden of informal dementia caregivers, an experience sampling study. Nurs Res. 2017;66(6):421–431.